A

    Alector Inc (ALEC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.26
    -0.08 (-3.42%)

    Market Cap: $261.28M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    61%(19/31)
    Avg Surprise
    -22.57%
    Streak
    14 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.23
    Range$-0.30 - $-0.19
    6 analysts
    EPS Revisions
    2
    0
    7d
    2
    1
    30d
    EPS Estimate Drift
    90d ago$-0.23+0.7%
    60d ago$-0.23+0.7%
    30d ago$-0.23+0.7%
    7d ago$-0.22+4.7%
    Current$-0.23
    Revenue Consensus
    $3M
    Range$500000 - $5M
    6 analysts
    Dec 31, 2026
    EPS Consensus$-0.13
    Range$-0.29 - $-0.03
    6 analysts
    Revenue Consensus
    $-4700070
    Range$-10310360 - $4M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.13---
    Sep 26EST
    		-$-0.23---
    Jun 26
    		$-0.21$-0.24+12.50%Beat+30.0%
    Mar 26
    		$-0.21$-0.27+22.22%Beat+48.8%
    Dec 25
    		$-0.34$-0.39+13.11%Beat-1600.0%
    Sep 25
    		$-0.34$-0.41+17.07%Beat+20.9%
    Jun 25
    		$-0.30$-0.45+33.33%Beat+25.0%
    Mar 25
    		$-0.41$-0.46+10.87%Beat-7.9%
    Dec 24
    		$-0.02N/A+96.33%Beat+95.9%
    Sep 24
    		$-0.43$-0.53+18.87%Beat+18.9%
    Jun 24
    		$-0.40$-0.48+16.67%Beat-2100.0%
    Mar 24
    		$-0.38$-0.49+22.45%Beat+30.9%
    Dec 23
    		$-0.49$-0.77+36.36%Beat+22.2%
    Sep 23
    		$-0.53$-0.65+18.46%Beat+5.4%
    Jun 23
    		$0.02N/A+102.44%Beat-83.3%
    Mar 23
    		$-0.55$-0.78+29.49%Beat-1.9%
    Dec 22
    		$-0.63$-0.46-36.96%Miss+7.4%
    Sep 22
    		$-0.56$-0.51-9.80%Miss-137.6%
    Jun 22
    		$0.12N/A+127.27%Beat+117.4%
    Mar 22
    		$-0.54$0.17-417.65%Miss+18.2%
    Dec 21
    		$-0.68$-0.19-257.89%Miss-3.0%
    Sep 21
    		$1.49$2.83-47.35%Miss+322.4%
    Jun 21
    		$-0.69$-0.69+0.00%Beat-19.0%
    Mar 21
    		$-0.66$-0.67+1.49%Beat-24.5%
    Dec 20
    		$-0.66$-0.66+0.00%Beat-46.7%
    Sep 20
    		$-0.67$-0.55-21.82%Miss-42.6%
    Jun 20
    		$-0.58$-0.50-16.00%Miss-61.1%
    Mar 20
    		$-0.53$-0.43-23.26%Miss-96.3%
    Dec 19
    		$-0.45$-0.44-2.27%Miss+69.6%
    Sep 19
    		$-0.47$-0.40-17.50%Miss-62.1%
    Jun 19
    		$-0.36$-0.32-12.50%Miss-
    Mar 19
    		$-0.27$-0.31+12.90%Beat-
    Dec 18
    		$-1.48$-0.28-428.57%Miss-
    Sep 18
    		$-0.29$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-2.05EV/EBITDA-8.40x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-735.00%
    ROE-385.10%ROIC96357.38%
    Financial Health
    Debt/Equity-0.99xInterest CoverageN/A
    Current Ratio5.26xQuick Ratio5.26x
    Trading Statistics
    Beta0.58Avg Volume1.53M
    52-Week High$3.4052-Week Low$1.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.34
    SMA 20$2.10
    SMA 50$1.84
    SMA 200$1.90
    EMA 10$2.28
    EMA 20$2.14
    EMA 50$1.97
    EMA 200$1.94

    MACD

    Line: 0.18Signal: 0.17Hist: 0.01

    ADX

    ADX: 38.6+DI: 27.7-DI: 13.7

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down20.0
    PSAR$2.52

    Bollinger Bands

    Upper Band$2.69
    Lower Band$1.51
    %B Position5659%(Upper)
    Band Width0.64

    RSI (14-Day)

    Neutral
    57.7

    Momentum Oscillators

    Stoch %K74.0
    Stoch %D82.4
    Williams %R-42.4
    ROC (10d)10.2%
    Momentum0.21
    CCI (20d)49.9
    MFI (14d)79.5

    Volatility Measures

    ATR (14d)$0.18(8.1%)
    StdDev (20d)0.30
    Hist Vol134.9%(High)

    Volume Flow

    VWAP$2.28
    OBV7.9M
    AD Line1.8M
    CMF (20d)0.229

    Volume Metrics

    Avg Vol (20d)1.6M
    Vol Ratio0.4x(Low)
    VWMA (20d)$2.11

    Pivot Points

    R3$2.54
    R2$2.49
    R1$2.42
    Pivot Point$2.37
    S1$2.29
    S2$2.24
    S3$2.17

    Advanced Oscillators

    TSI25.44
    Ultimate Osc48.1
    KST415.87

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$3.32M$1.05M$6.24M$3.26M$7.87M$3.67M$54.24M$15.34M$15.08M$15.89M$15.19M$9.11M
    Cost of Revenue$0$0$2.26M$0$0$0$46.46M$0$0$0$2.26M$0
    Gross Profit$3.32M$1.05M$6.24M$3.26M$7.87M$3.67M$54.24M$15.34M$15.08M$15.89M$15.19M$9.11M
    Operating Expenses$27.71M$25.96M$45.80M$40.87M$42.01M$48.37M$61.49M$63.78M$60.69M$59.60M$62.64M$59.69M
    R&D$19.46M$17.86M$32.46M$29.35M$27.61M$33.64M$46.46M$48.00M$46.31M$45.17M$47.72M$46.33M
    SG&A$8.25M$8.11M$13.34M$11.52M$14.40M$14.73M$15.03M$15.78M$14.38M$14.43M$14.92M$13.36M
    Operating Income$-24,393,000$-24,919,000$-39,566,000$-37,608,000$-34,138,000$-44,695,000$-7,249,000$-48,434,000$-45,606,000$-43,708,000$-47,453,000$-50,583,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-22,860,000$-22,930,000$-37,099,000$-34,667,000$-30,524,000$-40,471,000$-2,026,000$-42,220,000$-38,603,000$-36,072,000$-39,768,000$-43,223,000
    Income Tax Expense$130,000$0$168,000$0$0$0$48,000$0$73,000$7,000$1.67M$1.25M
    Net Income$-22,990,000$-22,930,000$-37,267,000$-34,667,000$-30,524,000$-40,471,000$-2,074,000$-42,220,000$-38,676,000$-36,079,000$-41,434,000$-44,475,000
    EBITDA$-21,233,000$-21,435,000$-36,008,000$-33,808,000$-28,989,000$-40,581,000$-2,527,000$-43,292,000$-40,280,000$-38,360,000$-42,318,000$-45,557,000
    EBIT$-22,860,000$-22,930,000$-37,099,000$-34,667,000$-30,524,000$-40,471,000$-2,026,000$-42,220,000$-38,603,000$-36,072,000$-39,768,000$-43,223,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ALEC

    News

    Alector (ALEC) CEO shifts 2.1M shares into family trusts

    Alector, Inc. (ALEC) CEO Arnon Rosenthal transferred 2.1 million shares of common stock among family trusts on August 19, 2026, as reported in a Form 4 filing. The shares were gifted from The Rosenthal Family Revocable Trust to three separate 2007 family trusts at a reported price of $0.0000 per share. After these transactions, Rosenthal directly holds 2,367,206 shares, with additional indirect holdings through the trusts where he serves as trustee.

    Stock Titan•8/21/26•
    Neutral

    Alector, Inc. (NASDAQ:ALEC) Receives Consensus Recommendation of "Hold" from Brokerages

    Alector, Inc. (NASDAQ:ALEC) has received a consensus "Hold" rating from eight brokerages, with an average 12-month price target of $3.625 against a current share price of $2.15. Despite beating quarterly earnings expectations with a smaller loss and higher revenue, the company remains deeply unprofitable, with analysts forecasting continued losses. Insider selling and institutional investment adjustments were also noted.

    MarketBeat•8/13/26•
    Neutral

    Industry Analysts Just Upgraded Their Alector, Inc. (NASDAQ:ALEC) Revenue Forecasts By 60%

    Analysts have significantly upgraded their near-term revenue forecasts for Alector, Inc. by 60%, pushing the consensus for 2026 revenues to US$11m, despite an expected 21% reduction in sales over the past 12 months. While losses per share are still expected, analysts reduced their loss estimates, indicating increased optimism. The stock has already seen a 36% increase, and it remains to be seen if this upgrade will further propel its value.

    Sahm•8/13/26•
    Bullish

    Industry Analysts Just Upgraded Their Alector, Inc. (NASDAQ:ALEC) Revenue Forecasts By 60%

    Analysts have significantly upgraded Alector, Inc.'s near-term revenue forecasts by 60%, with the consensus for 2026 now standing at US$11 million, despite an expected 21% reduction in sales over the past year. While losses per share are predicted to decrease by 19% to US$0.86, analysts anticipate Alector's revenue decline to accelerate faster than the wider industry. This positive sentiment from the revenue upgrade has coincided with a 36% rise in Alector's stock price over the past week.

    Simply Wall Street•8/12/26•
    Bullish

    HC Wainwright Issues Negative Outlook for Alector Earnings

    HC Wainwright has lowered its Q3 and full-year 2026 earnings estimates for Alector, forecasting a deeper loss per share despite the company beating revenue expectations in its latest quarterly results. Alector's stock opened down 5.1% at $1.69, and analysts currently hold a consensus "Hold" rating with an average price target of $3.62. Institutional investors own a significant 85.83% of the shares, while recent insider activity shows sales by the CEO and CFO.

    MarketBeat•8/11/26•
    Somewhat-Bearish

    Frequently Asked Questions About ALEC

    Does ALEC pay dividends?
    Alector Inc (ALEC) does not currently pay a regular dividend.
    What is ALEC's market cap?
    Alector Inc (ALEC) has a market capitalization of $261.28M with a current stock price of $2.26.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In